GenSight Biologics S.A. (EPA: SIGHT)

GenSight Biologics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.94	2.13	10.61	44.29	37.94	19.25
Cash & Short-Term Investments	6.94	2.13	10.61	44.29	37.94	19.25
Cash Growth	579.73%	-79.89%	-76.04%	16.72%	97.11%	-26.64%
Accounts Receivable	0.04	0	-	0.75	0.05	0.85
Other Receivables	1.27	2.4	3.49	3.54	3.21	5.26
Receivables	1.31	2.4	3.49	4.3	3.26	6.11
Prepaid Expenses	1.05	1.63	8.21	2.55	1.67	2
Other Current Assets	3.72	0.37	0.63	2.23	0.89	0.41
Total Current Assets	13.02	6.53	22.95	53.36	43.76	27.77
Property, Plant & Equipment	1.39	2.03	2.27	2.55	3.15	4.23
Other Intangible Assets	0.07	0.08	0.09	0.11	0.13	0.15
Other Long-Term Assets	0.52	0.5	0.63	0.62	0.32	0.34
Total Assets	14.99	9.13	25.94	56.65	47.36	32.48
Accounts Payable	4.78	5.63	7.81	11.56	7.59	7.14
Accrued Expenses	1.61	1.79	3.61	2.45	2.64	1.27
Current Portion of Long-Term Debt	5.79	16.61	1.54	4.68	2.41	0.5
Current Portion of Leases	0.88	0.78	0.89	0.74	0.56	0.56
Current Income Taxes Payable	0.02	0.03	0.03	0.02	0.02	0.63
Current Unearned Revenue	0	0.07	0.03	0.2	0.04	-
Other Current Liabilities	3.78	0.4	0.73	2.6	3.87	2
Total Current Liabilities	16.86	25.29	14.64	22.24	17.12	12.09
Long-Term Debt	15.45	5.11	14.46	10.58	14.12	7.01
Long-Term Leases	0.56	1.05	0.97	1.51	2.05	2.76
Long-Term Unearned Revenue	-	-	0.19	0.42	-	-
Other Long-Term Liabilities	5.79	7.13	10.93	5.86	2.29	-
Total Liabilities	39.82	39.83	41.22	40.66	35.61	21.97
Common Stock	2.6	1.63	1.16	1.16	1.02	0.82
Additional Paid-In Capital	201.4	190.94	181.21	181.18	152.78	128.13
Retained Earnings	-5.85	-26.22	-27.63	-28.62	-34.02	-30.87
Comprehensive Income & Other	-222.98	-197.05	-170.02	-137.73	-108.03	-87.57
Shareholders' Equity	-24.83	-30.7	-15.28	15.99	11.75	10.52
Total Liabilities & Equity	14.99	9.13	25.94	56.65	47.36	32.48
Total Debt	22.68	23.54	17.86	17.51	19.13	10.83
Net Cash (Debt)	-15.74	-21.4	-7.25	26.78	18.81	8.42
Net Cash Growth	-	-	-	42.36%	123.47%	-63.07%
Net Cash Per Share	-0.24	-0.44	-0.16	0.59	0.54	0.30
Filing Date Shares Outstanding	103.4	64.97	46.18	46.24	45.93	32.74
Total Common Shares Outstanding	103.4	64.97	46.18	46.24	45.93	32.74
Working Capital	-3.85	-18.76	8.31	31.12	26.64	15.68
Book Value Per Share	-0.24	-0.47	-0.33	0.35	0.26	0.32
Tangible Book Value	-24.9	-30.78	-15.37	15.88	11.62	10.36
Tangible Book Value Per Share	-0.24	-0.47	-0.33	0.34	0.25	0.32
Machinery	1.23	1.23	1.22	1.36	1.31	1.33
Leasehold Improvements	1.36	1.35	1.37	0.98	0.96	0.98

Source: S&P Capital IQ. Standard template. Financial Sources.